Sjogren's syndrome
Not recruitingSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
- Disease:Sjogren's syndrome
- Substances:Efgartigimod Alfa
Poland- Participants:18–64 years
- Substances:Efgartigimod Alfa
- Sponsor:Argenx
Rare diseases
Investigational molecules
Locations
Back to Poland2 clinical trials in Dopiewo, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on follicular lymphoma treatment, comparing new therapeutic approaches with standard care protocols.
Studies aim to assess both safety and effectiveness of new treatment combinations for improved patient outcomes.
Research initiatives targeting diffuse large B-cell lymphoma, exploring innovative combination therapies with chemotherapy protocols.
Focus on developing more effective treatments for previously untreated patients with specific risk profiles.
Groundbreaking research examining new treatments for Polycythemia Vera, evaluating novel therapeutic approaches.
Studies aim to improve disease control and reduce the need for traditional interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.